Literature DB >> 4078729

Acute tolerance development to the cardiovascular and subjective effects of cocaine.

M W Fischman, C R Schuster, J Javaid, Y Hatano, J Davis.   

Abstract

Eight normal adult volunteer subjects received an intranasal pretreatment of either 4 (placebo) or 96 mg of cocaine. Sixty minutes later 16, 32 or 48 mg of cocaine was injected i.v. Cocaine plasma levels were determined periodically over a 2-hr period and both cardiovascular effects and verbal report of drug effects were monitored for 8 hr daily. The plasma concentrations of cocaine were always related to the dose administered. When i.v. cocaine was given after a 96-mg intranasal pretreatment, the increase in heart rate was not as great as when an i.v. injection followed a 4-mg inhalation. Comparable changes were obtained in subjective effects as measured on the Addiction Research Center Inventory, the Profile of Mood States and a subjective effects questionnaire. These results suggest that there is a decrease in physiological and subjective effects of cocaine when administered repeatedly in humans. This acute tolerance appeared to have dissipated within 24 hr.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4078729

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

1.  Addiction changes orbitofrontal gyrus function: involvement in response inhibition.

Authors:  R Z Goldstein; N D Volkow; G J Wang; J S Fowler; S Rajaram
Journal:  Neuroreport       Date:  2001-08-08       Impact factor: 1.837

2.  The orbitofrontal cortex in methamphetamine addiction: involvement in fear.

Authors:  Rita Z Goldstein; Nora D Volkow; Linda Chang; Gene-Jack Wang; Joanna S Fowler; Richard A Depue; Ruben C Gur
Journal:  Neuroreport       Date:  2002-12-03       Impact factor: 1.837

Review 3.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

Review 4.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

5.  Liking and wanting of drug and non-drug rewards in active cocaine users: the STRAP-R questionnaire.

Authors:  R Z Goldstein; P A Woicik; S J Moeller; F Telang; M Jayne; C Wong; G J Wang; J S Fowler; N D Volkow
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

Review 6.  Pharmacokinetic-Pharmacodynamic (PKPD) Analysis with Drug Discrimination.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Curr Top Behav Neurosci       Date:  2018

7.  Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats.

Authors:  Christopher M Lack; Sara R Jones; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

8.  Determining the subjective and physiological effects of BZP on human females.

Authors:  Joanne C Lin; Nisha Bangs; Heeseung Lee; Rob R Kydd; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

9.  Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.

Authors:  R A Wise; E Munn
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 10.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.